Factors Influencing Attitude to Treatment among Patients with Type-2 Diabetes Mellitus in the Niger Delta, Nigeria

Factors Influencing Attitude to Treatment among Patients with Type-2 Diabetes Mellitus in the Niger Delta, Nigeria

Loading document ...
Loading page ...


Author(s): Agofure Otovwe, Odjimogho Stella, Okandeji-Barry Oghenenioborue

Download Full PDF Read Complete Article

DOI: 10.18483/ijSci.1866 71 272 34-41 Volume 7 - Dec 2018


Background: Type-2 Diabetes mellitus could be well managed if patients adhere strictly to treatment regimen. Patient’s attitude to treatment recommendations has been shown to influence level of adherence to treatment. This study was therefore designed to investigate factors influencing the attitude to treatment among patients with type-2 diabetes mellitus in the Niger Delta, Nigeria. Methodology: A cross-sectional study was conducted among 350 purposively selected patients with Type-2 diabetes mellitus. A semi-structured questionnaire was interviewer administered to obtain information on respondents’ socio-demographic characteristics, attitude to medication and dietary treatment, and factors influencing adherence to treatment. Descriptive statistics, Chi-square test and logistic regression were used to analyse the data with level of significance set at 0.05. Results: Mean age of respondents was 57.9 ± 9.8 years, 60.9% were females and 78.0% were married. Above average of respondents exhibited good attitude to medication (65.10%) and dietary (64.0%) treatment respectively. Analysis of the determinants of poor attitude to medication treatment shows; taking many drugs to get better quickly was the major contributing variable at (OR=2.08 95% CI=1.268-3.406). Major factors influencing adherence to medication and dietary treatment includes difficulty in sticking to recommended diet, Long queues and waiting times in the clinic; Side effects from recommended drugs and the least is doctors too busy to listen to patients complaints. Conclusion: Taking many drugs to get better quickly and many other factors influencing the attitude to treatment recommendations remains a challenge among patients with type-2 diabetes mellitus. Thus, health education on diabetic care with emphasis on improving attitude to medication and dietary treatment regimen, among other strategies, should be organised regularly for diabetic patients.


Attitude to treatment, Type-2 diabetes mellitus, Niger Delta


  1. World Health Organisation: Peer Support Programs in diabetes. A report of World Health Organization Consultation, 5-7 November 2007.
  2. Morbidity Mortality Weekly Report: Social Economic Status of women with diabetes United States 2000. A CDC weekly Report, Retrieved October 19, 2008.
  3. Silinik M: Impact of diabetes on health care and hospitalization. International Hospital Federation Reference Book. London: pro-book publishing limited; 2007: 54-57.
  4. International Diabetes Federation, Diabetes atlas: Diabetes facts, 2nd and 3rd. Retrieved April, 7, 2006 from http://www.worlddiabetesfoundation.org/composite-35.htm.
  5. Kengne AP, Amoah AGB, Mbanya JC: 2005. Cardiovascular Complications of Diabetes Mellitus in Sub-Saharan Africa. Journal of Circulation 2005, 112:3592–3601.
  6. World Health Organization, African Region: Nigeria. Retrieved March 4 2009.
  7. Popoola MM: Living with diabetes. The holistic experiences of Nigerians and African Americans. Holistic Nurse Practice 2005, 19: 10-16.
  8. Okolie U, Ehiemere I, Ezenduka P, Ogbu S: Contributory factors to Diabetes dietary regimen non adherence in adults with diabetes. World Academy of Science, Engineering and Technology 2010, 69: 743-741.
  9. Schechter C, Walker E: Improving Adherence to Diabetes Self-Management Recommendations. Diabetes Spectrum 2002, 15; 3: 170-175.
  10. Haynes RB, Taylor, Sackett DL.Compliance in healthcare. Baltimore, MD: Johns Hopkins University Press; 1979:1–7.
  11. Jackevicius CA, Mamdani M, Tu JV: Adherence with statin therapy in elderly patients with and without acute coronary syndromes. Journal of the America Medical Association 2002, 288:462-7.
  12. Cramer J, Rosenheck R, Kirk G, Krol W, Krystal J: Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes. Value Health 2003, 6:566-73.
  13. Haynes RB, McDonald HP, Garg AX: Helping patients follow prescribed treatment:clinical applications. Journal of the America Medical Association 2002 288:2880-3.
  14. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J: Long-term persistence in use of statin therapy in elderly patients. Journal of the America Medical Association 2002, 288:455-61.
  15. Rozenfeld Y, Hunt JS, Plauschinat C, Wong KS: Oral anti diabetic medication adherence and glycaemic control in managed care. America Journal of Management Care 2008 14:71-75.
  16. Blanca RD, Blanca RC, Ernesto FG: Pharmacological therapy compliance in diabetes. Salud Publica de Mexico 2001, 43:233–236.
  17. Lo R: Correlates of expected success at adherence to health regimen of people with IDDM. Journal of Advance Nursing 1999, 30(2):418–424.
  18. Anderson RM, Fitzgerald JT, Oh MS: The relationship of diabetes related attitudes and patients' self-reported adherence. Diabetes Education 1993, 19:287-292.
  19. McLarty DG, Pollitt C, Swai AB: Diabetes in Africa. Diabetes Medicine 1990, 7:670–84.
  20. Neuhann H, Water-Neuhann C, Lyaruu I, Msuya L: Diabetes care in Kilimanjaro region: clinical presentation and problem of patients of the diabetes clinic at the regional referral hospital-an inventory before structured intervention. Diabetes Medicine 2002, 19(6): 509-513.
  21. Beran D, Yudkin J: Diabetes care in Sub-Saharan Africa. Lancet 2006, 368:1689-1695.
  22. Dagogo-Jack S: Ethnic disparities in type 2 diabetes: management. Journal of the National Medical Association 2006, 95(9): 774-789.
  23. Kiawi E, Edwards R, Shu J, Unwin N, Kamadjeu R, Mbanya JC: Knowledge, attitudes and behaviour relating to diabetes and its main risk factors among urban residents in Cameroon: A qualitative survey. Ethnicity & Disease 2006, 16:503-509.
  24. Kazeem BV, Olubunmi O, Bonatson YJ: Adherence to anti-diabetic drug therapy and self management practices among type 2 diabetics in Nigeria. Pharmacy World Science 2008, 30:876-883.
  25. Linda CC: Health education and Health promotion. Suzame C. S. and Brenda, G. B. Eds. Brunner and Sudddarth’s textbook of medical surgical nursing 10th edition, Lippincott William and Wilkins; 2004, Pp 46-47.
  26. Delameter AM: Improving Patient Adherence. Diabetes Care 2007, 30:1107-1112.
  27. Prado-Aguilar CA, Martínez YV, Segovia-Bernal Y, Reyes-Martínez R, Arias-Ulloa R: Performance of two questionnaires to measure treatment adherence in patients with Type-2 Diabetes BMC Public Health 2009, 9:38
  28. Thompson AV, Neil HAW, Thorogood M, Fowler GH, Mann JI: Diabetes mellitus: attitudes, knowledge and glycaemic control in a cross-sectional population. Journal of the Royal college of General practitioners 1988, 38:450-452.
  29. Okuno J, Yanagi H, Tomura S: 2001. Is cognitive impairment a risk factor for poor compliance among Japanese elderly in the community? European Journal of Clinical Pharmacology 2001, 57:589-594.
  30. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV: Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. Journal of Clinical Psychiatry 2002, 63:892-909.
  31. Van Servellen G, Chang B, Garcia L, Lombardi E: Individual and system level factors associated with treatment non adherence in human immunodeficiency virus infected men and women. AIDS Patient Care STDS 2002, 16:269-281.
  32. Perkins DO: Predictors of noncompliance in patients with schizophrenia. Journal of Clinical Psychiatry 2002, 63:1121-1128.
  33. Balkrishnan R: Predictors of medication adherence in the elderly. Clinical Therapy 1998, 20:764-71.
  34. Ellis JJ, Erickson SR, Stevenson JG: Sub optimal state in adherence and discontinuation in primary and secondary prevention populations. Journal of General Internal Medicine 2004, 19:638-45.
  35. Kennedy J, Erb C: Prescription noncompliance due to cost among adults with disabilities in the United States. American Journal of Public Health 2002, 92(7):1120–4.
  36. Tamblyn R, Laprise R, Hanley JA, Abrahamowicz M, Scott S, Mayo N: Adverse events associated with prescription drug cost-sharing among poor and elderly persons. Journal of the America Medical Association 2001, 285(4):421–429.
  37. Adisa R, Alutundu MB, Fakeye TO: Factors contributing to non adherence to oral hypoglycaemic medications among ambulatory type 2 diabetes patients in southwestern Nigeria. Pharmacy Practice 2009, 3:163-169.
  38. Ary DV, Toobert D, Wilson W, Glasgow RE: Patient perspective on factors contributing to nonadherence to diabetes regimen. Diabetes Care 1986, 9:168-172.

Cite this Article:

International Journal of Sciences is Open Access Journal.
This article is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) License.
Author(s) retain the copyrights of this article, though, publication rights are with Alkhaer Publications.

Search Articles

Issue June 2023

Volume 12, June 2023

Table of Contents

World-wide Delivery is FREE

Share this Issue with Friends:

Submit your Paper